Unilever Increases Stake In India Subsidiary To 67%, Short Of Goal
This article was originally published in PharmAsia News
Unilever's effort to buy a larger stake in its Hindustan Unilever subsidiary in India fell short of its goal of 75%, but will still cost $3.2 billion accepted by enough shareholders to give it 67.28%.
You may also be interested in...
This month’s column covers deals announced between 1-23 April 2020.
In an interview with Medtech Insight, Biotronik president Ryan Walters explained why the former Mayo Clinic cardiologist was the right choice to be the first CMO in the company's history and David Hayes discussed his reasons for taking the job.
Pandemic-related collaborations between Hoth/VCU; Sorrento/Mt. Sinai Health; Audax/Northeastern U.; Alkido/U. of Maryland, Baltimore; Active Motif/Hisun BioRay/Fudan U. and more.